首页> 外文期刊>Substance Abuse Treatment, Prevention, and Policy >The impact of prescription opioids on all-cause mortality in Canada
【24h】

The impact of prescription opioids on all-cause mortality in Canada

机译:处方阿片类药物对加拿大全因死亡率的影响

获取原文
           

摘要

An influential study from the United States generated considerable discussion and debate. This study documented rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century, with clear linkages of all-cause mortality to increasing rates of poisonings, suicides and chronic liver disease deaths. All of these causes of deaths are strongly related to the use of legal and illegal substances, but the study stressed the importance of prescription opioids. Given the similarities between the United States and Canada in prescription opioid use, the assessment of similar all-cause mortality trends is relevant for Canada. As this commentary highlights, the all-cause mortality shifts seen in the United States cannot be seen in Canada for either sex or age groups. The exact reasons for the differences between the two countries are not clear, but it is important for public health to further explore this question.
机译:来自美国的一项有影响力的研究引起了广泛的讨论和辩论。这项研究记录了21世纪白人非西班牙裔美国人中年发病率和死亡率的上升,而全因死亡率与中毒,自杀和慢性肝病死亡率的上升之间存在明显的联系。所有这些死亡原因均与合法和非法物质的使用密切相关,但该研究强调了处方阿片类药物的重要性。鉴于美国和加拿大在处方阿片类药物使用方面的相似性,对类似全因死亡率趋势的评估与加拿大有关。正如该评论所强调的那样,无论是性别还是年龄组,在美国都无法看到在美国看到的全因死亡率变化。两国之间差异的确切原因尚不清楚,但对公共卫生而言,进一步探讨这一问题很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号